The average one-year price target for Editas Medicine (NASDAQ:EDIT) has been revised to 13.68 / share. This is an increase of 5.56% from the prior estimate of 12.96 dated June 1, 2023. The price ...
The average one-year price target for Editas Medicine (NasdaqGS:EDIT) has been revised to $4.95 / share. This is an increase of 22.78% from the prior estimate of $4.03 dated November 14, 2025. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback